Subscribe to this column
Clifford A. Hudis, MD, FASCO, FACP
Clifford A. Hudis, MD, FACP, FASCO, is the CEO of ASCO, executive vice chair of Conquer Cancer, the ASCO Foundation, and chair of CancerLinQ. Prior to these roles, he served as chief of the Breast Medicine Service and an attending physician at Memorial Sloan Kettering Cancer Center and as a professor in the Department of Medicine at Weill Cornell Medical College. He is a past president of ASCO. His research interests include all areas of care related to breast cancer, with a focus on the development of novel systemic therapies and prevention interventions related to obesity and inflammation. Follow Dr. Hudis on Twitter @CliffordHudis.
Jun 04, 2020
A spirit of clinically relevant discovery and accessible, understandable knowledge dissemination is the profound legacy, responsibility, and obligation that Rich will leave at ASCO, and we will honor him by continuing this work at the level of rigor and quality he established.
May 26, 2020
Dr. Ray Page and I discuss the important role that drug repository programs can play in helping our patients afford their treatment while reducing the financial toll on the cancer care delivery system.
May 20, 2020
We have an urgent need to learn more about how COVID-19 is directly and indirectly affecting the people with cancer whom we serve.
Apr 20, 2020
Dr. Jason Westin explains the science behind the transformative CAR T-cell therapy, and the financial concern it presents to our health care system and our patients.
Apr 07, 2020
Dr. Robert Miller and I discuss electronic medical records, interoperability, and ASCO's role in developing a set of standardized data elements for oncology.
Mar 10, 2020
ASCO's chief medical officer Dr. Richard L. Schilsky and I discuss the refinement of cancer surgery, the critical importance of federally funded research, and ASCO's research priorities for the oncology community.
Latest Blogs